ALS acquires pharmaceutical analysis laboratory ARJ in Latin America

ALS acquires pharmaceutical analysis laboratory ARJ in Latin America

Posted 04 October 2019
Located in Mexico City, ARJ is the leading pharmaceutical analysis laboratory in Latin America.

Founded in 1967 and employing over 500 employees, ARJ specializes in providing quality control services for medicines, medical equipment, healing material, food, beverages, cosmetics and chemicals to major pharmaceutical companies globally.

About ARJ

Established since 1967 in Mexico City, ARJ started offering chemical and microbiology analyses of vitamins and antibiotics; quantification of active pharmaceutical ingredients by UV- Visible Spectrophotometry and pyrogens tests.

In 1970, the laboratory moved to Colonia Granjas - México, adding CLG/FID tests to its services portfolio. In 1996, after four expansion refurbishments on the same building, the construction works of the current building started, having and initial 1300 m2 surface and 54 employees. In 2008, the third and fourth floor were added in new refurbishment to the building. With the purpose of increasing capacity for microbiology and biology tests, a new 2400 m2 microbiology laboratory was built in 2012. In 2017, started the construction works for the third 6000 m2 building that opened in April 2018.

Currently, with three buildings covering an overall 12000m2 surface and over 500 employees, ARJ offers almost all methods required by different pharmacopoeias.

Accreditation

  • Sanitary License issued by COFEPRIS based on Mexican Norm NMX-EC-17025-IMNC- “General Requirements for the Competence of Analyses and Calibration Laboratories” 
  • Laboratory authorized by SADER (Rural Development and Agriculture Secretary), in compliance with Mexican Norm NOM-062-ZOO-1999
  • GLP certificate issued by INVIMA, Colombian National Institute for the Food and Drug Surveillance.

Certifications available in: arj.mex

Analyses

Some of the analyses performed in different areas:

Atomic absorption
Antibiotics and vitamins
Gas chromatography
Liquid chromatography
Medical devices
Microbiology
Biology tests
Dissolution testing
Chemistry preparation
Biology products

See complete scope in: arj.mex

About acquisition

ARJ acquisition aligns and supports our non-cyclical businesses 2022 growth strategic plan within the Group, offering a solid platform to continue increasing our presence in key markets such as Argentina, Brazil, Colombia and Mexico and is expected to benefit from the Group's regional and global presence to further expand its offer to customers.

This is a great opportunity for both companies to evolve and grow even more in this truly unique business sector bringing huge benefits to all participants.

In reference to the acquisition, ALS CEO and Managing Director Raj Naran commented, “I am really excited to announce the merger of two large long-standing companies. ALS and ARJ come together to expand our service offer, promoting a fully aligned business culture and strategy. It is an exciting opportunity for both companies to continue evolving and growing in this truly unique business sector. As a global company, ALS prides itself on its internal culture of diversity, mutual respect and support, as well as the external principles of excellent customer service and accessibility from anywhere in the world. We welcome the ARJ team aboard the ALS team and wish him much success in this new stage.”

Related Articles

X
alsglobal.com uses cookies to help improve your experience on our website. By continuing you consent for cookies to be used. More info
Confirm